AlphaCrest Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,199
| Closed | -$2.26M | – | 1157 |
|
|
2022
Q3 | $2.26M | Buy |
9,199
+4,166
| +83% | +$1.03M | 0.14% | 192 |
|
|
2022
Q2 | $1.52M | Buy |
5,033
+3,020
| +150% | +$913K | 0.07% | 466 |
|
|
2022
Q1 | $827K | Sell |
2,013
-117
| -5% | -$48.1K | 0.05% | 642 |
|
|
2021
Q4 | $999K | Sell |
2,130
-772
| -27% | -$362K | 0.04% | 789 |
|
|
2021
Q3 | $1.23M | Sell |
2,902
-2,422
| -45% | -$1.03M | 0.06% | 517 |
|
|
2021
Q2 | $1.91M | Buy |
5,324
+4,613
| +649% | +$1.66M | 0.08% | 380 |
|
|
2021
Q1 | $200K | Sell |
711
-1,767
| -71% | -$497K | 0.01% | 1147 |
|
|
2020
Q4 | $702K | Buy |
2,478
+1,302
| +111% | +$369K | 0.06% | 471 |
|
|
2020
Q3 | $323K | Buy |
+1,176
| New | +$323K | 0.04% | 821 |
|
|
2020
Q1 | – | Sell |
-2,950
| Closed | -$443K | – | 1301 |
|
|
2019
Q4 | $443K | Buy |
2,950
+589
| +25% | +$88.5K | 0.04% | 866 |
|
|
2019
Q3 | $335K | Sell |
2,361
-10
| -0.4% | -$1.42K | 0.02% | 1075 |
|
|
2019
Q2 | $297K | Sell |
2,371
-597
| -20% | -$74.8K | 0.03% | 861 |
|
|
2019
Q1 | $327K | Buy |
+2,968
| New | +$327K | 0.05% | 621 |
|